This work studied the descriptive validity of the balanced scorecard as a causal model for leading and lagging measurements of non-financial and financial performance in relation to time-lag effects.
The estimation accuracy can be substantially improved if some form of dynamic information is included into the models, either by augmenting the process data matrix with lagged measurements, or by averaging the process measurements values on a moving window of fixed length.
The combination of current and lagged measurements did not increase the contribution of BMI (percentage explained 25.8% [95% CI 16.8 38.1]).
The aim of this work is to compare the time lag measurements from these two methods, and check if there is a connection with other emission line properties.
The current balanced scorecard literature suggests that a link should exist between lagging and leading measurements of non-financial performance perspectives and financial performance measures.
In addition, the 1-month lag avoids measurement error inherent in the 0-month lag coefficient in which births early in the month may occur prior to economic downturns later in that month.
Our observation of effect modification by diabetic status in the associations between the cumulative effect and 4 hr before ECG measurement lag effect of BC and NO2 exposure and prolonged QTc for the QCDL and hourly lag models may be due to a higher likelihood of persons with diabetes to have prolonged QTc than those without diabetes.
Embedding at sampling instance T, the first step of SSA, involves the process of generating a trajectory matrix ({mathbf M}_{i}={mathbf {m}_{i,t} vert t=T-L T} in mat=T-L T}^{K tines L}) of lag L mathbbement vectors, where each vector (phantom {R}^{{i}!}mathbf {m}_{i,t'}={m_{i,t'} vert t'=t-K:timesencodes the measurements corresponding to a sampL}ng windof of laggth K for sensor i.
As training and establishment of services in intervention villages will require time to be achieved, this lag in measurement is necessary to ensure exposure to the intervention.
(E ) Representative traces of currents evoked by 100 µM baclofen show Lag time measurement as time between the onset of agonist removal and the point at which 10% of the current deactivated: 1560, 4900 and 3000 ms for WT, Rgs7 −/−, R7bp −/−, respectively.
